Literature DB >> 33940189

Does vitamin D serum level affect prognosis of COVID-19 patients?

Maryam Nasiri1, Javad Khodadadi2, Sedigheh Molaei3.   

Abstract

BACKGROUND: Since beginning of Coronavirus disease of 2019 (COVID-19) pandemic, there were contradictions and speculations around vitamin D and COVID-19 relationship. Given that there is association between vitamin D deficiency and some diseases including cancer, autoimmune disease and some infectious diseases, COVID-19 higher incidence rate and mortality in vitamin D deficient population was not a surprise. Conversely, some research would argue this relationship. Considering these contradictions, the aim of this study was to determine the relationship between prognosis and vitamin D level in cases with COVID-19.
METHODS: In this cross-sectional study, 329 confirmed cases of COVID-19 which admitted to Kamkar-ArabNia Hospital in Qom city, Iran from March to July 2020 were categorized into three groups according to vitamin D serum levels (ng/ml): sufficient (>30), insufficient (20-30) and deficient (<20). Prognosis was determined across the groups.
RESULTS: There was significant difference in hospital stay between patients with sufficient and insufficient vitamin D levels (P = 0.007). Adjusting vitamin D levels for confounding variables, linear regression underscored significant differences in the association between length of hospitalization and lower vitamin D levels, with a longer stay noted in insufficient groups (P = 0.002). However, there was no significant difference in the time interval to return to normal oxygen level (from SpO2 below 93%) or death rate between groups (P > 0.05).
CONCLUSION: There is significant association between hospital stay and lower serum vitamin D levels. However, the relationship between vitamin D status and death rate or the time interval to return to normal oxygen levels is not significant.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  COVID-19; Prognosis; Vitamin D

Year:  2021        PMID: 33940189     DOI: 10.1016/j.ijid.2021.04.083

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

Review 1.  Vitamin D and COVID-19-Revisited.

Authors:  Sreedhar Subramanian; George Griffin; Martin Hewison; Julian Hopkin; Rose Anne Kenny; Eamon Laird; Richard Quinton; David Thickett; Jonathan M Rhodes
Journal:  J Intern Med       Date:  2022-07-15       Impact factor: 13.068

2.  Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection.

Authors:  Liam Townsend; Adam H Dyer; Patrick McCluskey; Kate O'Brien; Joanne Dowds; Eamon Laird; Ciaran Bannan; Nollaig M Bourke; Cliona Ní Cheallaigh; Declan G Byrne; Rose Anne Kenny
Journal:  Nutrients       Date:  2021-07-15       Impact factor: 5.717

3.  The potential significance of vitamin D binding protein polymorphism in COVID-19.

Authors:  Marijn M Speeckaert; Joris R Delanghe
Journal:  Int J Infect Dis       Date:  2021-06-24       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.